Search Within

Andrew D Seidman

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (12)
  2. Journal Article (7)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (19)
  2. Breast Medicine Service (19)
  3. Department of Medicine (19)
  4. GSK Faculty (19)
  5. Human Oncology and Pathogenesis Program (19)
  6. Solid Tumor Oncology Division (19)

More Groups

People
  1. Adrienne Boire (11)
  2. Elena Pentsova (10)
  3. Jonathan Yang (7)
  4. Rachna Malani (7)
  5. Sarat Chandarlapaty (7)
  6. Shanu Modi (7)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (5)
  4. 2021 (1)
  5. 2020 (2)
  6. 2017 (1)

More Years

Publications
  1. Journal of Clinical Oncology (5)
  2. Cancer Research (3)
  3. International Journal of Radiation Oncology, Biology, Physics (3)
  4. Neuro-Oncology (3)
  5. npj Breast Cancer (2)
  6. Clinical Breast Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. Elsevier Inc. (4)
  3. American Association for Cancer Research (3)
  4. Oxford University Press (3)
  5. Nature Publishing Group (2)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (19)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer
    Journal Article

    Malani, R.; Fleisher, M.; Kumthekar, P.; Lin, X.; Omuro, A.; Groves, M. D.; Lin, N. U.; Melisko, M.; Lassman, A. B.; Jeyapalan, S.; more...
    Journal of Neuro-Oncology (2020)

    Fulltext@MSK | Save
  • Characteristics and outcomes of patients with breast cancer with leptomeningeal metastasis
    Journal Article

    Morikawa, A.; Jordan, L.; Rozner, R.; Patil, S.; Boire, A.; Pentsova, E.; Seidman, A. D.
    Clinical Breast Cancer (2017)

    Fulltext@MSK | Save
  • Treatment options of long term survivors with leptomeningeal metastases and breast cancer
    Meeting Abstract

    Chaul-Barbosa, C.; Morikawa, A.; Patil, S.; Boire, A.; Jordan, L.; Rozner, R.; Seidman, A.; Pentsova, E.
    Neuro-Oncology (2016)

    Fulltext@MSK | Save
  • Optimization of intermittent high dose lapatinib administration with or without capecitabine: A rational approach to drug dosing and scheduling using Norton-Simon modeling
    Meeting Abstract

    Morikawa, A.; De Stanchina, E.; Patil, S.; Chandarlapaty, S.; Li, B. T.; Norton, L.; Seidman, A. D.
    Cancer Research (2016)

    Fulltext@MSK | Save
  • Characteristics and outcomes of breast cancer patients with leptomeningeal metastasis at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Morikawa, A.; Jordan, L.; Rozner, R.; Patil, S.; Boire, A. A.; Pentsova, E.; Seidman, A. D.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer
    Meeting Abstract

    Cadoo, K. A.; Shah, P. D.; Charen, A. S.; Bromberg, J.; Comen, E. A.; D'Andrea, G.; Dang, C. T.; Gilewski, T.; Gucalp, A.; Lake, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Modi, S.; Drullinsky, P.; Syldor, A.; Patil, S.; Seidman, A.; Norton, L.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I study in patients with metastatic HER2-amplified breast cancer
    Meeting Abstract

    Gajria, D.; King, T. A.; Pannu, H.; Sakr, R.; Seidman, A. D.; Syldor, A.; Patil, S.; Maybody, M.; Norton, L.; Rosen, N.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I/II study in patients with metastatic HER2-amplified or triple-negative breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Seidman, A. D.; Modi, S.; Dickler, M.; Drullinsky, P.; Syldor, A.; Sujata, P.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save